Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil

Pediatr Infect Dis J. 2013 May;32(5):e182-5. doi: 10.1097/INF.0b013e3182814eae.

Abstract

Background: The aim of this study was to compare clinical manifestations, laboratory data, morbidity and mortality between adults and children with visceral leishmaniasis, with a focus on kidney function.

Methods: This was a retrospective cohort study with 432 patients with visceral leishmaniasis diagnosed at 1 center in the northeast of Brazil. Patients were divided into 2 groups according to age (>21 years and ≤ 21 years old).

Results: The time between onset of symptoms and beginning of treatment was longer in adults (89.5 versus 48.5 days, P < 0.001); signs and symptoms were similar in both groups. Failure of treatment with glucantime was more common in adults (17.6% versus 8.8%, P = 0.008). Acute kidney injury was observed in 160 patients (37.0%), and it was more severe in adults. Risk factors for acute kidney injury in adults were hypokalemia, leukopenia, chills and amphotericin B use. In children, secondary infections were found to increase the risk for acute kidney injury. Overall mortality was 8.8%, and it was significantly higher in adults (12.6% versus 4.1%, P = 0.002).

Conclusions: The adult population had more severe laboratory abnormalities and a worse prognosis, possibly due to delay in diagnosis. Acute kidney injury is prevalent in both groups, and it is usually more severe in adults.

Publication types

  • Comparative Study

MeSH terms

  • Acute Kidney Injury / parasitology
  • Adolescent
  • Adult
  • Aged
  • Antiprotozoal Agents / therapeutic use
  • Brazil / epidemiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Leishmaniasis, Visceral / drug therapy
  • Leishmaniasis, Visceral / epidemiology*
  • Leishmaniasis, Visceral / mortality
  • Leishmaniasis, Visceral / physiopathology
  • Male
  • Meglumine / therapeutic use
  • Meglumine Antimoniate
  • Middle Aged
  • Organometallic Compounds / therapeutic use
  • Retrospective Studies
  • Risk Factors
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Antiprotozoal Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate